Folate and Vitamin B12 Status in Pediatric Hematopoietic Stem Cell Transplantation Patients
Nutrients · 2025
DOI: 10.3390/nu17030377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Gizem Zengin Ersoy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology & Oncology and Stem Cell Transplantation Department, Umraniye Training and Research Hospital, Health Sciences University, 34668 …. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Folic Acid, Vitamin B 12, Vitamin B 12 Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Vitamin B12 and folic acid (FA) are crucial for children’s hematopoiesis after hematopoietic stem cell transplantation (HSCT). This study evaluates the B12 and FA level changes before and after HSCT.
Methods
We retrospectively collected data from 125 patients who underwent HSCT between March 2019 and February 2024. B12 and FA levels were measured at three time points: before transplantation, one month after, and six months after. Sixty-two patients had complete data. B12 deficiency was defined as levels < 200 pg/mL and insufficiency as 200–300 pg/mL. Folate deficiency was classified as insufficiency ≤ 3 ng/mL, indeterminate for 4.0–5.8 ng/mL and typical for 5.9–26.8 ng/mL. Patients with B12 < 300 pg/mL and folic acid < 5 ng/mL were treated at all stages.
Results
Among the 62 patients, 24 (38.7%) were girls, with a median age of 4 years (1.75–8.25). Median B12 levels were 398 pg/mL (pre-transplant), 892 pg/mL (1 month post), and 430 pg/mL (6 months post). The second time point had significantly higher B12 levels (p < 0.001). Median folate levels were 9.7 ng/mL, 6.95 ng/mL, and 11.3 ng/mL at the respective time points (p < 0.05), with the second time point significantly lower.
Conclusions
Pediatric HSCT patients experience increased demands for B12 and FA despite accurate treatment, leading to potential deficiencies. Close monitoring, early supplementation, and supplementing high levels of these micronutrients are essential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Hematology & Oncology and Stem Cell Transplantation Department, Umraniye Training and Research Hospital, Health Sciences University, 34668 Istanbul, Türkiye.
ORCID-Profile: Gizem Zengin Ersoy, Begüm Şirin Koç, Suar Çakı Kılıç
Zitieren
APA
Zengin Ersoy, G., Koç, B. Ş., & Çakı Kılıç, S. (2025). Folate and Vitamin B12 Status in Pediatric Hematopoietic Stem Cell Transplantation Patients. Nutrients. https://doi.org/10.3390/nu17030377
Vancouver
Zengin Ersoy G, Koç BŞ, Çakı Kılıç S. Folate and Vitamin B12 Status in Pediatric Hematopoietic Stem Cell Transplantation Patients. Nutrients. 2025. doi:10.3390/nu17030377
BibTeX
@article{ZenginErsoy2025,
author = {Zengin Ersoy, Gizem and Koç, Begüm Şirin and Çakı Kılıç, Suar},
title = {Folate and Vitamin B12 Status in Pediatric Hematopoietic Stem Cell Transplantation Patients},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17030377}
}
EUVIMED